Cargando…
Identification of a Novel Susceptibility Marker for SARS-CoV-2 Infection in Human Subjects and Risk Mitigation with a Clinically Approved JAK Inhibitor in Human/Mouse Cells
Coronavirus disease (COVID-19), caused by SARS-CoV-2, has affected over 65 million individuals and killed over 1.5 million persons (December 8, 2020; www.who.int)(1). While fatality rates are higher among the elderly and those with underlying comorbidities(2), host factors that promote susceptibilit...
Autores principales: | Spalinger, Marianne R., Hai, Rong, Li, Jiang, Santos, Alina N., Nordgren, Tara M., Tremblay, Michel L., Eckmann, Lars, Hanson, Elaine, Scharl, Michael, Wu, Xiwei, Boland, Brigid S., McCole, Declan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743066/ https://www.ncbi.nlm.nih.gov/pubmed/33330862 http://dx.doi.org/10.1101/2020.12.09.416586 |
Ejemplares similares
-
Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB
por: Spalinger, Marianne, et al.
Publicado: (2021) -
Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence
por: Spalinger, Marianne Rebecca, et al.
Publicado: (2022) -
Activation of Protein Tyrosine Phosphatase Non-Receptor Type 2 by Spermidine Exerts Anti-Inflammatory Effects in Human THP-1 Monocytes and in a Mouse Model of Acute Colitis
por: Morón, Belén, et al.
Publicado: (2013) -
PTPN2 Is a Critical Regulator of Ileal Paneth Cell Viability and Function in Mice
por: Canale, Vinicius, et al.
Publicado: (2023) -
JAK-STAT Pathway Regulation of Intestinal Permeability: Pathogenic Roles and Therapeutic Opportunities in Inflammatory Bowel Disease
por: Lei, Hillmin, et al.
Publicado: (2021)